Naturhouse Health, S.A. (NTH.MC)

Naturhouse Health, S.A. (NTH.MC) — VMCI valuation read

NTH.MC screens at VMCI 60/100, a 10-point gap above the Consumer Defensive sector median (50). For a mid-cap Naturhouse Health, S.A. share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

NTH.MC has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: NTH.MC trades at 26.0x earnings, 44% above the Consumer Defensive median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Defensive group. Quality: ROIC of 16.0% sits 6.0pp above the Consumer Defensive median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.8x leaves covenant headroom, which sets the rate-cycle exposure for Naturhouse Health, S.A..

NTH.MC fell 2.0% over the trailing 7 days, with a -3.4% read on a 30-day basis.